These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11145736)

  • 1. Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor.
    Wan Y; Coxe KK; Thackray VG; Housley PR; Nordeen SK
    Mol Endocrinol; 2001 Jan; 15(1):17-31. PubMed ID: 11145736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants.
    Nishi M; Ogawa H; Ito T; Matsuda KI; Kawata M
    Mol Endocrinol; 2001 Jul; 15(7):1077-92. PubMed ID: 11435609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide repeat proteins.
    Banerjee A; Periyasamy S; Wolf IM; Hinds TD; Yong W; Shou W; Sanchez ER
    Biochemistry; 2008 Sep; 47(39):10471-80. PubMed ID: 18771283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fluorescent protein-tagged and cyan fluorescent protein-tagged imaging analysis of glucocorticoid receptor and importins in single living cells.
    Tanaka M; Nishi M; Morimoto M; Sugimoto T; Kawata M
    Endocrinology; 2003 Sep; 144(9):4070-9. PubMed ID: 12933681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
    Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geldanamycin, an inhibitor of Hsp90, blocks cytoplasmic retention of progesterone receptors and glucocorticoid receptors via their respective ligand binding domains.
    Kakar M; Kanwal C; Davis JR; Li H; Lim CS
    AAPS J; 2006 Nov; 8(4):E718-28. PubMed ID: 17233535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity.
    Li H; Fidler ML; Lim CS
    Mol Pharm; 2005; 2(6):509-18. PubMed ID: 16323958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor.
    Boruk M; Savory JG; Haché RJ
    Mol Endocrinol; 1998 Nov; 12(11):1749-63. PubMed ID: 9817600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.
    Wang D; Simons SS
    Mol Endocrinol; 2005 Jun; 19(6):1483-500. PubMed ID: 15774497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor.
    Savory JG; Hsu B; Laquian IR; Giffin W; Reich T; Haché RJ; Lefebvre YA
    Mol Cell Biol; 1999 Feb; 19(2):1025-37. PubMed ID: 9891038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of glucocorticoid receptor in the brain of green fluorescent protein-glucocorticoid receptor knockin mice.
    Usuku T; Nishi M; Morimoto M; Brewer JA; Muglia LJ; Sugimoto T; Kawata M
    Neuroscience; 2005; 135(4):1119-28. PubMed ID: 16154291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity.
    Schaaf MJ; Cidlowski JA
    Mol Cell Biol; 2003 Mar; 23(6):1922-34. PubMed ID: 12612067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor.
    Yoshikawa N; Makino Y; Okamoto K; Morimoto C; Makino I; Tanaka H
    J Biol Chem; 2002 Feb; 277(7):5529-40. PubMed ID: 11741935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera.
    Htun H; Barsony J; Renyi I; Gould DL; Hager GL
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4845-50. PubMed ID: 8643491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antipeptide antibodies to the human glucocorticoid receptor: recognition of multiple receptor forms in vitro and distinct localization of cytoplasmic and nuclear receptors.
    Cidlowski JA; Bellingham DL; Powell-Oliver FE; Lubahn DB; Sar M
    Mol Endocrinol; 1990 Oct; 4(10):1427-37. PubMed ID: 1704480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras.
    Lim CS; Baumann CT; Htun H; Xian W; Irie M; Smith CL; Hager GL
    Mol Endocrinol; 1999 Mar; 13(3):366-75. PubMed ID: 10076994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.
    Georgiakaki M; Chabbert-Buffet N; Dasen B; Meduri G; Wenk S; Rajhi L; Amazit L; Chauchereau A; Burger CW; Blok LJ; Milgrom E; Lombès M; Guiochon-Mantel A; Loosfelt H
    Mol Endocrinol; 2006 Sep; 20(9):2122-40. PubMed ID: 16645042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination.
    Zhang S; Liang X; Danielsen M
    Mol Endocrinol; 1996 Jan; 10(1):24-34. PubMed ID: 8838142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.